S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2020-08	Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial Catenacci, Daniel V. T.; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E.; Lee, Keun-Wook; Ng, Matthew C. H.; Enzinger, Peter C.; Park, Se Hoon; Gold, Philip J.; Lacy, Jill; Hochster, Howard S.; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A.; Kelly, Ronan J.; Juergens, Rosalyn A.; Kim, Jong Gwang; Bendell, Johanna C.; Alcindor, Thierry; Sym, Sun Jin; Song, Eun-Kee; Chee, Cheng Ean; Chao, Yee; Kim, Sunnie; Lockhart, A. Craig; Knutson, Keith L.; Yen, Jennifer; Franovic, Aleksandra; Nordstrom, Jeffrey L.; Li, Daner; Wigginton, Jon; Davidson-Moncada, Jan K.; Rosales, Minori Koshiji; Bang, Yung-Jue The Lancet Oncology, Vol.21 No.8, pp.1066-1076	DOI
2021-08	Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium Shimizu, Toshio; Kim, Dong-Wan; Loong, Herbert H.; Lin, Chia-Chi; Ng, Matthew C. H.; Yamamoto, Noboru; Ma, Brigette; Tan, Daniel S. W. Asia-Pacific Journal of Clinical Oncology, Vol.17 No.4, pp.388-395	DOI